Garuda Therapeutics
Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe diseases and has raised significant funding to advance its innovative technology.
Services
Garuda Therapeutics develops off-the-shelf hematopoietic stem cell (HSC) therapies aimed at treating a wide variety of severe and life-threatening diseases. Their platform technology generates self-renewing blood stem cells, providing patients with rapid and broad access to consistent, durable, HLA-compatible transgene-free blood stem cell therapies. The company's goal is to make these therapies available to cure more than 70 diseases and eliminate the dependency on donor or patient cells.
Platform Technology
Garuda Therapeutics' core technology focuses on generating self-renewing blood stem cells. This innovative approach provides consistent and durable solutions, ensuring patients have access to HLA-compatible transgene-free blood stem cell therapies. This technology is designed to replace the need for donor or patient cells, potentially curing over 70 different diseases. Their technology was also featured by the National Institutes of Health (NIH) in November 2021, highlighting its significance in the medical field.
Funding Rounds
Garuda Therapeutics has successfully closed multiple funding rounds to support its innovative technology. In September 2021, the company raised $72 million in a Series A financing round. More recently, Garuda Therapeutics closed a $62 million Series B round in February 2023, focusing on advancing their off-the-shelf, self-renewing blood stem cell technology. These funds are aimed at enhancing their research and expanding their capabilities in providing advanced stem cell therapies.
Partnerships
In May 2023, Garuda Therapeutics announced a working partnership with Be The Match BioTherapies®. This collaboration aims to provide robust cell therapy infrastructure, leveraging Be The Match BioTherapies®'s extensive network and expertise. Such strategic partnerships are crucial for Garuda Therapeutics as it continues to develop and scale its innovative hematopoietic stem cell therapies.
Company Location
Garuda Therapeutics is headquartered at 215 First St., Suites 340-350, Cambridge, MA 02142. This location positions the company in a prominent biotech hub, facilitating access to resources, talent, and collaborations necessary for advancing their innovative stem cell therapies.